Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony L Johnson

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Brain : a Journal of Neurology|February 1, 2011
The long-term risk of premature mortality in people with epilepsyAidan Neligan, Gail S Bell, Anthony L Johnson, et al.
Developmental Cell|August 22, 2018
Essential Function of Mec1, the Budding Yeast ATM/ATR Checkpoint-Response Kinase, in Protein HomeostasisIsaac Corcoles-Saez, Kangzhen Dong, Anthony L Johnson, et al.
Plos One|August 8, 2012
Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysisPaul McCrone, Michael Sharpe, Trudie Chalder, et al.
Trials|April 16, 2015
Sharing data from clinical trials: the rationale for a controlled access approachMatthew R Sydes, Anthony L Johnson, Sarah K Meredith, et al.
Neuroscience Letters|June 7, 2005
Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathologyStephen B Wharton, Gareth H Williams, Kai Stoeber, et al.
Plos Genetics|July 5, 2013
Budding yeast ATM/ATR control meiotic double-strand break (DSB) levels by down-regulating Rec114, an essential component of the DSB-machineryJesús A Carballo, Silvia Panizza, Maria Elisabetta Serrentino, et al.
Trials|November 15, 2013
A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis planRebecca Walwyn, Laura Potts, Paul McCrone, et al.
The Lancet. Neurology|October 22, 2005
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Lancet (London, England)|November 16, 2004
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Epilepsia|August 24, 2010
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classificationJohn P Osborne, Andrew L Lux, Stuart W Edwards, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Brain : a Journal of Neurology|February 1, 2011
The long-term risk of premature mortality in people with epilepsyAidan Neligan, Gail S Bell, Anthony L Johnson, et al.
Developmental Cell|August 22, 2018
Essential Function of Mec1, the Budding Yeast ATM/ATR Checkpoint-Response Kinase, in Protein HomeostasisIsaac Corcoles-Saez, Kangzhen Dong, Anthony L Johnson, et al.
Plos One|August 8, 2012
Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysisPaul McCrone, Michael Sharpe, Trudie Chalder, et al.
Trials|April 16, 2015
Sharing data from clinical trials: the rationale for a controlled access approachMatthew R Sydes, Anthony L Johnson, Sarah K Meredith, et al.
Neuroscience Letters|June 7, 2005
Expression of Ki67, PCNA and the chromosome replication licensing protein Mcm2 in glial cells of the ageing human hippocampus increases with the burden of Alzheimer-type pathologyStephen B Wharton, Gareth H Williams, Kai Stoeber, et al.
Plos Genetics|July 5, 2013
Budding yeast ATM/ATR control meiotic double-strand break (DSB) levels by down-regulating Rec114, an essential component of the DSB-machineryJesús A Carballo, Silvia Panizza, Maria Elisabetta Serrentino, et al.
Trials|November 15, 2013
A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis planRebecca Walwyn, Laura Potts, Paul McCrone, et al.
The Lancet. Neurology|October 22, 2005
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Lancet (London, England)|November 16, 2004
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialAndrew L Lux, Stuart W Edwards, Eleanor Hancock, et al.
Epilepsia|August 24, 2010
The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classificationJohn P Osborne, Andrew L Lux, Stuart W Edwards, et al.
Pageof 3